• Nichi-Iko®
  • Serialization/Track and Trace
  • Investors
  • Careers
  • Anti-Capital Punishment Statement
  • Contact Us
  • Online Ordering Portal
  • sagentbiosimilars.com
  • zoledronicpremix.com
  • glydo.com
Sagent PharmaceuticalsSagent Pharmaceuticals
Sagent Pharmaceuticals
  • Home
  • About
    • Our Executive Team
    • Who We Are
    • What We Do
    • Why We Do It
  • Products
  • PreventIV Measures®
Home > Serialization/Track and Trace > FDA Guidance
  • Are you ready
  • Connecting with Sagent
  • FDA Guidance
  • Read the Laws (Congress and FDA)

FDA Guidance

  • DSCSA Implementation: Product Tracing Requirements — Compliance Policy
  • DSCSA Implementation: Product Tracing Requirements for Dispensers — Compliance Policy (Revised) Guidance for Industry
  • DSCSA Standards for the Interoperable Exchange of Information for Tracing of Certain Human, Finished, Prescription Drugs: How to Exchange Product Tracing Information
  • Drug Supply Chain Security Act Implementation: Identification of Suspect Product and Notification Guidance for Industry
  • Back
    www.SagentPharma.com Site Map Privacy Terms of Use for Site(s) Sales Terms & Conditions

    The SAGENT logo, SAGENT, SAGENT Pharmaceuticals and PreventIV Measures are registered trademarks of Sagent Pharmaceuticals, Inc.
    The Nichi-Iko logo, NICHI-IKO and NIKP are registered trademarks of Nichi-Iko Pharmaceutical Co., Ltd.
    © 2023 Sagent Pharmaceuticals, Inc.